School of Medicine

Wayne State University School of Medicine

Dr. LoRusso featured in Sept. 7 Stand Up To Cancer primetime fundraiser

Dr. LoRusso with Karmanos melanoma patient Hillary Kind.

Dr. LoRusso with Karmanos melanoma patient Hillary Kind.

Filming a segment at the Karmanos Cancer Center for the Sept. 7 Stand Up To Cancer primetime special are Dr. LoRusso; Lawrence Flaherty, M.D.; and Cynthia Marsack, M.S.N., R.N.

Filming a segment at the Karmanos Cancer Center for the Sept. 7 Stand Up To Cancer primetime special are Dr. LoRusso; Lawrence Flaherty, M.D.; and Cynthia Marsack, M.S.N., R.N.

Patricia LoRusso, D.O., professor of Oncology at Wayne State University School of Medicine and director of Phase I Clinical Trials and the Eisenberg Center for Experimental Therapeutics at the Barbara Ann Karmanos Cancer Institute, will be featured in the Stand Up To Cancer primetime fundraising telecast airing live Sept. 7, from 8 to 9 p.m.

Dr. LoRusso is co-leader of the Stand Up To Cancer-Melanoma Research Alliance Melanoma Dream Team.

SU2C is a program of the Entertainment Industry Foundation, the 501(c)(3) not-for-profit organization that serves as the collective philanthropy for the television and film businesses. EIF has distributed hundreds of millions of dollars to support programs addressing critical health, education and social issues. EIF created SU2C, a collaboration to build public support for groundbreaking translational research accelerating the delivery of new therapies to patients, getting them from the “bench to the bedside” as quickly as possible. The scientific partner of SU2C is the American Association for Cancer Research, the world’s largest professional organization dedicated to advancing cancer research. SU2C brings together scientists from different disciplines across the nation’s various institutions to collaborate on innovative cancer research.

Dr. LoRusso co-leads the SU2C-Melanoma Research Alliance Melanoma Dream Team with Jeffrey Trent, Ph.D., of Translational Genomics Research Institute in Phoenix, Ariz. They’re developing personalized therapies for individuals with highly aggressive BRAF wild-type metastatic melanoma. There are few current treatment options for patients with this disease.

Dr. LoRusso will be among the Dream Team leaders attending the Sept. 7 SU2C primetime special in Los Angeles. It will air nationally, commercial-free and simultaneously, on ABC, CBS, FOX and NBC, as well as on numerous cable networks both nationally and internationally. Dr. LoRusso and some of her patients, along with Karmanos staff, will be showcased in an inspirational segment during the television program.

This is the third SU2C primetime special since 2008. It will be viewed in approximately 190 countries and involve numerous celebrities/performers who are donating their services for this global fundraising event. All donations received will go toward cancer research.
Bookmark and Share